ECSP18039827A - Anticuerpo que neutraliza el virus respiratorio sincitial humano - Google Patents

Anticuerpo que neutraliza el virus respiratorio sincitial humano

Info

Publication number
ECSP18039827A
ECSP18039827A ECIEPI201839827A ECPI201839827A ECSP18039827A EC SP18039827 A ECSP18039827 A EC SP18039827A EC IEPI201839827 A ECIEPI201839827 A EC IEPI201839827A EC PI201839827 A ECPI201839827 A EC PI201839827A EC SP18039827 A ECSP18039827 A EC SP18039827A
Authority
EC
Ecuador
Prior art keywords
neutralizes
antibody
human
antibodies
respiratory virus
Prior art date
Application number
ECIEPI201839827A
Other languages
English (en)
Inventor
Zhang Lan
Chen Zhifeng
Tang Aimin
Su Hua-Poo
Distefano Daniel
A Vora Kalpit
S Cox Kara
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of ECSP18039827A publication Critical patent/ECSP18039827A/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a anticuerpos monoclonales que tienen altos títulos neutralizantes anti-VRS. La invención proporciona además ácidos nucleicos aislados que codifican los anticuerpos de la invención y células huésped transformadas con los mismos. La invención proporciona aún además métodos de diagnóstico, profilácticos y terapéuticos que emplean los anticuerpos y ácidos nucleicos de la invención, particularmente como un agente de inmunoterapia pasiva en lactantes y ancianos.
ECIEPI201839827A 2015-10-29 2018-05-24 Anticuerpo que neutraliza el virus respiratorio sincitial humano ECSP18039827A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562247841P 2015-10-29 2015-10-29

Publications (1)

Publication Number Publication Date
ECSP18039827A true ECSP18039827A (es) 2018-07-31

Family

ID=61159870

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201839827A ECSP18039827A (es) 2015-10-29 2018-05-24 Anticuerpo que neutraliza el virus respiratorio sincitial humano

Country Status (2)

Country Link
AR (1) AR106471A1 (es)
EC (1) ECSP18039827A (es)

Also Published As

Publication number Publication date
AR106471A1 (es) 2018-01-17

Similar Documents

Publication Publication Date Title
NI201800052A (es) Anticuerpos que neutraliza el virus respiratorio sincitial humano
MX2021007679A (es) Anticuerpos humanos para hemaglutinina de influenza.
UA116999C2 (uk) Виділене антитіло до гемаглютиніну та фармацевтична композиція, що його містить
JO3664B1 (ar) أجسام مضادة لـ tigit
BR112016015140A2 (pt) imunoglobulina com fabs in-tandem e usos das mesmas
UY36006A (es) Construcciones de proteína uspa2 y usos de las mismas.
EA032929B1 (ru) Нейтрализующее вирус иммунодефицита человека антитело и способы его применения
MX370191B (es) Composiciones y su uso en el tratamiento de la inmunodeficiencia.
GT201500046A (es) Mètodos para el tratamiento de infecciones de hepatitis b y hepatitis d
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
BR112018003526A2 (pt) métodos de tratamento de doenças inflamatórias
BR112017015880A2 (pt) anticorpos, usos e métodos
AR100944A1 (es) ANTICUERPOS ANTAGONISTAS DE INTERFERÓN a Y w
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
UA116697C2 (uk) Композиція для запобігання зараженню видами роду mycoplasma
ECSP18039827A (es) Anticuerpo que neutraliza el virus respiratorio sincitial humano
WO2013173256A3 (en) New and improved influenza vaccines
WO2014188212A3 (en) Treatment and prevention of malaria
EA201591933A1 (ru) Композиция с пониженной иммуногенностью
EA201891048A1 (ru) Антитело, нейтрализующее респираторно-синцитиальный вирус человека
PH12017500928A1 (en) A rabies composition comprising pika adjuvant
MX2013002764A (es) Vacuna epitopica a partir de un epitope inmunogenico de la neuraminidasa del virus de la influenza ah1n1 y metodo para la obtencion del mismo.
AR099553A1 (es) Construcciones de proteína uspa2 y usos de las mismas